Literature DB >> 3561382

Amyotrophic lateral sclerosis. Its natural history.

J T Caroscio, M N Mulvihill, R Sterling, B Abrams.   

Abstract

ALS is the most common of the various MNDs, which also include the clinical entities of PBP, PMA, and PLS. Mean age of onset of ALS is 57 years, and there is a sex predilection for men in a ratio of 1.5:1. Area of first symptom is in the lower extremity is 36 per cent of cases, in the upper extremity in 32 per cent, and 25 per cent of patients have a bulbar onset. Motor cranial nerves in the lower brain stem from cranial nerve nuclei or corticobulbar tract degeneration are affected. This results in symptoms of speech and swallowing difficulty and emotional lability in up to 60 per cent of cases. One hundred per cent of cases have motor weakness, over 90 per cent have muscle atrophy and fasciculations, and 47 per cent have spasticity. There seems to be a pattern of progression of ALS signs and symptoms based on area of onset with LLE involvement tending to follow RLE weakness, LUE weakness following RUE onset, and RUE involvement following next in patients whose onset is bulbar. Significant numbers of ALS patients had sparing of involvement of parts of the body for follow-up times approaching 3 years. Although the majority of patients experience a deterioration that is significantly linear, seven of 28 patients or 25 per cent achieved a plateau lasting a minimum of 9 months. Survival in our series was 4.08 years for all forms of MND.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3561382

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  30 in total

1.  Signs of impaired selective attention in patients with amyotrophic lateral sclerosis.

Authors:  Elmar H Pinkhardt; Reinhart Jürgens; Wolfgang Becker; Matthias Mölle; Jan Born; Albert C Ludolph; Herbert Schreiber
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

Review 3.  ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

Authors:  John M Ravits; Albert R La Spada
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

Review 4.  Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration.

Authors:  Steven A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

5.  Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  S Fadilah Abdul Wahid; Zhe Kang Law; Nor Azimah Ismail; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

6.  Tongue electrical impedance in amyotrophic lateral sclerosis modeled using the finite element method.

Authors:  Adam Pacheck; Alex Mijailovic; Sung Yim; Jia Li; Jordan R Green; Courtney E McIlduff; Seward B Rutkove
Journal:  Clin Neurophysiol       Date:  2015-12-11       Impact factor: 3.708

7.  Alteration of enzymatic activities implicating neuronal degeneration in the spinal cord of the motor neuron degeneration mouse during postnatal development.

Authors:  K Fujita; K Shibayama; M Yamauchi; T Kato; M Ando; H Takahashi; K Iritani; N Yoshimoto; Y Nagata
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

8.  Is IVIg therapy warranted in progressive lower motor neuron syndromes without conduction block?

Authors:  Neil G Simon; Gretchen Ayer; Catherine Lomen-Hoerth
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

9.  Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register.

Authors:  Raeburn B Forbes; Shuna Colville; Robert J Swingler
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

10.  Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency.

Authors:  Pierluigi Carratù; Lucia Spicuzza; Anna Cassano; Mauro Maniscalco; Felice Gadaleta; Donato Lacedonia; Cristina Scoditti; Ester Boniello; Giuseppe Di Maria; Onofrio Resta
Journal:  Orphanet J Rare Dis       Date:  2009-03-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.